Why Has Amphastars Stock Taken a Drastic Turn This Year?
| AMPH Stock | USD 36.37 0.05 0.14% |
Under 61% of Amphastar's investor base is looking to short. The analysis of overall sentiment of trading Amphastar P stock suggests that many investors are alarmed at this time. Amphastar's investing sentiment shows overall attitude of investors towards Amphastar P.
Amphastar |
Why Has Amphastars Stock Taken a Drastic Turn This Year
Read at kalkinemedia.com
 |
Amphastar Fundamental Analysis
We analyze Amphastar's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amphastar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amphastar based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Amphastar is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Amphastar P Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amphastar stock to make a market-neutral strategy. Peer analysis of Amphastar could also be used in its relative valuation, which is a method of valuing Amphastar by comparing valuation metrics with similar companies.
Peers
Amphastar Related Equities
| EVO | Evotec SE | 6.40 | ||||
| NBIX | Neurocrine Biosciences | 1.73 | ||||
| ALKS | Alkermes Plc | 1.11 | ||||
| PCRX | Pacira BioSciences, | 0.81 | ||||
| PAHC | Phibro Animal | 0.37 | ||||
| ANIP | ANI Pharmaceuticals | 0.35 | ||||
| COLL | Collegium Pharmaceutical | 0.28 | ||||
| PBH | Prestige Brand | 0.47 | ||||
| SUPN | Supernus Pharmaceuticals | 0.79 | ||||
| IRWD | Ironwood Pharmaceuticals | 2.11 | ||||
| EOLS | Evolus | 2.40 |
Complementary Tools for Amphastar Stock analysis
When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |